GERMS MDPI

27/08/2026

New published! 🚨

🫀 with and Involvement: An Unusual Diagnostic Presentation—A Case Report | Available: 🌐 https://brnw.ch/21x5eQ0

👥by Victoria Birlutiu, Ioana Maria Cobirje and Rares-Mircea Birlutiu

🧠 The case describes a 76-year-old patient whose initial presentation was dominated by and symptoms, while subsequent evaluation revealed involvement and .

🔬Initial showed no vegetations. Repeated were key to the diagnosis, while later confirmed extensive involvement with severe .

📚 Read more about this complex diagnostic presentation here: https://www.mdpi.com/2248-2997/16/3/21

Lucian Blaga University of Sibiu
Carol Davila University of Medicine and Pharmacy
Spitalul Clinic De Ortopedie Si Traumatologie Foisor

24/08/2026

💉How can counselling influence patients’ decisions about pneumococcal vaccination?

Adult remains an important priority in Romania, yet evidence on how physician training translates into patient-level outcomes is still limited.

📢 We invite you to read this recently published paper in Germs:
Changes in Patient Attitudes and After Pneumococcal Vaccination Counselling by Trained Family Physicians: A Multicentre Implementation Study in Romania 🫁

by Roxana Surugiu, Virginia-Maria Rădulescu, Anca Deleanu, Anca Lăcătuș, Mirela Mustață, Dana Fărcășanu, Iulia Vișinescu, Alexandra Aurora Dumitra and Gheorghe Gindrovel Dumitra

📌 This multicentre implementation study explores changes in patient , vaccination intention, and self-reported or appointment scheduling following counselling delivered by trained family physicians across three Romanian settings.

Rather than comparing training approaches as causal interventions, the study provides a real-world look at how different and implementation contexts may shape patient responses.

📖 Read the full paper here: https://brnw.ch/21x5ajN

21/08/2026

📢 We are pleased to highlight a recently published paper exploring the clinical presentation, management, and long-term outcomes of in adults.

👉 Clinical Features, , and of Chikungunya in : A Scoping Review

by Putu Cahyani Paramita Yoga, Agatha Viviane, and Ni Putu Dila Iswarani Dewi | 🏛️University of Pendidikan Ganesha

is not always self-limiting. While the is typically characterized by and marked , symptoms may persist well beyond the initial . 🦠

➡️Persistent and can have a significant impact on patients’ , highlighting the importance of recognizing and addressing long-term disease manifestations.

📖 We invite you to explore the full paper here:
https://brnw.ch/21x56Q1

04/08/2026

📢 We are excited to announce that GERMS MDPI is now part of MDPI's Journal Cluster of !

This collaboration brings together leading journals dedicated to publishing high-quality research that advances our understanding of the and its impact on human health, medicine, the environment, and technology.

📌As part of this initiative, Germs is proud to contribute its expertise in microbiology, with a particular focus on , , esistance, and other research that advances human health.

🌏 The Journal Cluster of Microbiology provides researchers with a broader publishing network and helps authors identify the journal that best matches the scope and audience of their work.
We look forward to working alongside our fellow journals to advance microbiology research and support the global scientific community.

Looking for the right journal for your microbiology research? Learn more here: 👉 https://brnw.ch/21x4F5u

Journal of Fungi MDPI
Microorganisms MDPI
Viruses MDPI
Pathogens MDPI
Fermentation MDPI
GERMS MDPI

29/07/2026

🦠 Yesterday was —a reminder that viral hepatitis remains a major global public health challenge.

Although scientific advances have transformed the and management of , eliminating the disease will require broader access to high-quality , effective therapeutics, and , alongside continued research, education, and international collaboration.

📖 On this occasion, we invite you to explore this perspective:

"Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH)"

✍️by Oana Săndulescu, İmran Hasanoğlu, Mojca Matičič and on behalf of ESGVH

🔗 Read the full article here: https://brnw.ch/21x4vKF

Carol Davila University of Medicine and Pharmacy
National Institute for Infectious Diseases "Prof. Dr. Matei Balș"
Academy of Romanian Scientists
Executive Committee of the ESCMID Study Group for Viral Hepatitis (ESGVH)
Ankara Yildirim Beyazit University
University Medical Centre Ljubljana

24/07/2026

📣 New publication in 👉 https://brnw.ch/21x4nSy

📄 "Genomic and Antigenic Evolution of Influenza A(H3N2) After the COVID-19 Era: A Scoping Review with Focus on J and K Subclades and Implications for Vaccine Effectiveness"

📌 In this review, authors synthesise the latest evidence on the and evolution of A( ), with a special focus on the emerging J and K subclades and their implications for vaccine effectiveness and .

👉As continue to undergo , timely remains critical for detecting emerging variants, informing vaccine composition, and strengthening global preparedness.

🔗 Read the article:
https://brnw.ch/21x4nSx

👥 Authors: Angelo Cianciulli, Emanuela Santoro, Salvatore Esposito, Savino Quaglierella, Antonietta Pacifico, Michele Nappa, Domenico Fornino, Roberta Manente, Mario Capunzo & Giovanni Boccia

🏛️ University of Salerno, Ospedale San Giovanni di Dio e Ruggi d'Aragona

22/07/2026

🦠 New in !

Can exposure before stem cell reshape the ?

This newly published study explores the impact of pre-transplant antibiotic exposure on the gut microbiome of patients undergoing (allo-HSCT), providing valuable insights into factors that may influence transplant outcomes.

🔬 Key findings:
🧫 Gut microbiome diversity was significantly lower in transplant recipients than in healthy controls.
💊 Pre-transplant antibiotic exposure was associated with reduced microbial diversity.
🌱 The findings reinforce the importance of in pre-transplant care to help preserve the gut microbiome and potentially improve transplant outcomes.

📖 Read the full open-access article:
https://brnw.ch/21x4kU6

👩‍🔬 Authors: Lavinia-Eugenia Lipan, Karina-Doris Vihta, Andra-Daniela Marcu, Irina Avramescu, Dumitru Jardan, Andi Palade, Anca Colita, Simona-Olimpia Dima, Ileana Constantinescu, Iuliana Iordan, Alexandra Marcoci, Oana-Gabriela Craciun, Cristina Negulescu and Alina Daniela Tănase

🏛️Carol Davila” University of Medicine and Pharmacy, Fundeni Clinical Institute, MedLife Romania, National Registry of Voluntary Hematopoietic Stem Cell Donors

16/07/2026

📢 Thank you to everyone who applied for the Germs and to everyone who shared our call with their networks.

The application deadline passed on 30 June, and we are now halfway through the selection process. We appreciate the time and effort that all applicants put into their submissions.

🎉 We look forward to announcing our new Early Career Editorial Board members soon—stay tuned!

👉 In the meantime, if you'd like to explore other opportunities to work with Germs, or have any questions, please contact us at [email protected] 📩

🔥 Exciting Opportunity! 🔥

GERMS MDPI looking for 10 passionate early-career scientists to join our Early Career Editorial Board ( )!

This role offers the opportunity to gain editorial experience, contribute to the development of an international journal, and build a foundation for future leadership roles within Germs.

Are you ready to:
🚀 Boost your academic visibility
🤝 Connect with a global network of experts
🧬 Shape the future of research

Researchers working in microbiology, virology, infectious diseases, public health, or related fields are invited to contribute to the development of these areas and their worldwide impact.

🔗 Learn more and apply here: https://brnw.ch/21wYj5m

Make sure you share the opportunity with an early-career researcher who shouldn’t miss this!

MDPI MDPI Romania

03/07/2026

📢 New Publication in !

We are delighted to feature this important study, co-authored by our respected Editorial Board Member, Dr. Casper Rokx, together with Dr. Ferdinand W. N. M. Wit, Prof. Marc van der Valk and Prof. Bart J. A. Rijnders.

"Comparable Treatment Efficacy of Switching to / Versus in People with After 2 Years of Follow-Up: The DUALING Prospective Nationwide Matched Cohort Study" | 🌐 https://brnw.ch/21x3Qtn

🏛️ Stichting HIV Monitoring,
🏛️ Amsterdam Umc - Locatie Amc
🏛️ Erasmus MC

📌Aim: To determine whether durable can be maintained after switching to dolutegravir/lamivudine in routine clinical practice, providing real-world evidence to support this .

💡Key finding: In this nationwide prospective clinical practice study, switching to dolutegravir/lamivudine was noninferior to continuing triple-drug antiretroviral therapy after two years of follow-up, supporting the long-term effectiveness of this simplified regimen in
people with HIV.

Read the full paper here 👉 https://brnw.ch/21x3Qtn

22/04/2026